Should the dose of antiplatelet drugs be adjusted for body weight? The example of vorapaxar. Cardiology 2016;133:69‑72.Serebruany VL, Fortmann SD, Kim MH. Should the dose of antiplate- let drugs be adjusted for body weight? The example of vorapaxar. Cardiology. 2016;133(2):69-72....
The development of nonsteroidal anti-inflammatory drugs (NSAIDs) selective for cyclooxygenase (COX)-2 (named coxibs) has been driven by the aim of reducing the incidence of serious gastrointestinal (GI) adverse events associated with the administration of traditional (t) NSAIDs – mainly dependent...
In patients who are at high risk of cardiovascular disease, it may recommend further testing, medication (statins, antihypertensive drugs, and antiplatelets), and lifestyle changes. The point-of-care decision support is aided by a "traffic light" (red, amber, and green) visual alert to flag...
of platelet-dependent aldosterone prothrombotic action in mice369Development of a method for in vivo detection of active thrombi in mice370The antiplatelet effects of structural analogs of the taurine chloramine371The influence of heparin anticoagulant drugs on functional state of human platelets372...
The development of nonsteroidal anti-inflammatory drugs (NSAIDs) selective for cyclooxygenase (COX)-2 (named coxibs) has been driven by the aim of reducing the incidence of serious gastrointestinal (GI) adverse events associated with the administration of traditional (t) NSAIDs – mainly dependent...